Stay updated on Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial
Sign up to get notified when there's something new on the Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial page.

Latest updates to the Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedLocations section updated with numerous new sites across multiple US states and countries, and several sites removed. Revision: v3.3.3.SummaryDifference0.8%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedRevision: v3.3.2 is now displayed on the page, replacing the previous Revision: v3.3.1. This appears to be a minor metadata update with no changes to the study content or user-facing functionality.SummaryDifference0.0%

- Check38 days agoChange DetectedAdded a PubMed auto-fill note stating that publications are automatically pulled from PubMed and may not pertain to the study. Updated the page revision to v3.3.1 (replacing v3.2.0).SummaryDifference0.0%

- Check45 days agoChange DetectedThe funding lapse notice banner warning that information may not be up to date has been removed from the study page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedThe study page content remains unchanged, with only minor UI layout or timestamp differences observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check81 days agoChange DetectedLocation region label updated from Rhone-Alpes to Auvergne-Rhône-Alpes; Pierre-Bénite, Rhone-Alpes, France, 69495 is replaced with Pierre-Bénite, Auvergne-Rhône-Alpes, France, 69495.SummaryDifference0.1%

Stay in the know with updates to Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial page.